Brazil’s National Agency of Supplementary Health (ANS) decided today to block a deal that would transfer 340,000-plus individual healthcare plans from Amil — the country’s fourth-largest HMO — to APS, owned by the same parent company, the U.S.-based UnitedHealth Group.
This portfolio would then be sold to a group of investors, but regulators were concerned the deal could be detrimental to patients. Friday’s decision confirms an injunction from earlier this month that ordered Amil to take back control of the portfolio as a precautionary measure.
Amil and APS were given five days to confirm the contract’s cancelation. The companies have not returned a request for comment.
The relationship between farmers and the Luiz Inácio Lula da Silva administration is by no…
Pelé, Ronaldo, Zico, Marta … All of Brazil’s truly immortal sporting icons are footballers, that…
Speaking before a Senate hearing on Tuesday, Chief of Staff Rui Costa admitted that Brazil…
New job market data from the Brazilian Institute of Geography and Statistics (IBGE) show the…
Brazil officially had 5.83 million domestic workers in 2022 — almost the entire population of…
Brazil’s Ministry of Health this month announced a purchase of 12.5 million doses of Moderna’s…